Search Results - Val Gebski

Refine Results
  1. 1
    Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.

    Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. by T P Gavaghan, Val Gebski, D. Baron

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

    Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer by Sandra Turner, S Gruenewald, Nigel Spry, Val Gebski

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature

    Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and sy... by Jannah Baker, Andreas Obermair, Val Gebski, Monika Janda

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by paramedics only

    The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by para... by Alan Garner, K. Mann, Michael R. Fearnside, Elwyn Poynter, Val Gebski

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective

    Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective by Val Gebski, Marivic Lagleva, Anthony Keech, John Simes, Allan O. Langlands

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Modelling interrupted time series to evaluate prevention and control of infection in healthcare

    Modelling interrupted time series to evaluate prevention and control of infection in healthcare by Val Gebski, Katherine Ellingson, Jonathan R. Edwards, John A. Jernigan, David G. Kleinbaum

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Randomised controlled trial of the Lidcombe programme of early stuttering intervention

    Randomised controlled trial of the Lidcombe programme of early stuttering intervention by Mark Jones, Mark Onslow, Ann Packman, Shelley Williams, Tika Ormond, Ilsa Schwarz, Val Gebski

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Swallowing performance after radiation therapy for carcinoma of the esophagus

    Swallowing performance after radiation therapy for carcinoma of the esophagus by Ian C. O'Rourke, K. W. Tiver, Colin A. Bull, Val Gebski, A.O. Langlands

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men

    Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men by P. Y. Liu, Val Gebski, Leo Turner, Ann J. Conway, Susan M. Wishart, David J. Handelsman

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

    Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of... by Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth G. Thurston, David Cade, Guy A. Van Hazel

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial

    Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cance... by Anna L. Hawkes, Michael Quinn, Val Gebski, Jane E. Armes, Donal J. Brennan, Monika Janda, Andreas Obermair

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

    Markers of systemic inflammation predict survival in patients with advanced renal cell cancer by Peter Fox, Harold Hudson, Chris Brown, Sarah J. Lord, Val Gebski, Paul de Souza, Chee Khoon Lee

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Metastatic cutaneous squamous cell carcinoma of the head and neck

    Metastatic cutaneous squamous cell carcinoma of the head and neck by Nicolas Oddone, Gary J. Morgan, Carsten E. Palme, Lakmalie Perera, Jennifer Shannon, Eva Wong, Val Gebski, Michael Veness

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

    Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis by Chee Khoon Lee, Johnathan Man, Sarah J. Lord, Matthew Links, Val Gebski, Tony Mok, James Chih‐Hsin Yang

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma

    Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma by Eugene Wong, Najmun Nahar, Eric Hau, Winny Varikatt, Val Gebski, Thomas S.C. Ng, Jayasingham Jayamohan, Puma Sundaresan

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals

    Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals by Nicholas P. West, Peggy L. Horn, David B. Pyne, Val Gebski, Sampo J. Lahtinen, Peter Fricker, Allan W. Cripps

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

    Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer by Bruce N. Gray, Guy van Hazel, MD Thomas A. Hope, Mark A. Burton, Paul Moroz, J Anderson, Val Gebski

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease

    Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Re... by Kenneth F. Bradstock, Ian Bilmon, John Kwan, Kenneth Micklethwaite, Emily Blyth, Stephanie Deren, Angela Bayley, Val Gebski, David Gottlieb

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

    Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer by M. D. Green, Prudence A. Francis, Val Gebski, V. Harvey, Christos S. Karapetis, Arlene Chan, Ray Snyder, Akiko Fong, R. Basser, John Forbes

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

    Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Sm... by Pei N. Ding, Sarah J. Lord, Val Gebski, Matthew Links, Victoria Bray, Richard J. Gralla, James Chih‐Hsin Yang, Chee Khoon Lee

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: